GL1X · GenesisL1 explorer

UniProt P25787

Proteasome subunit alpha type-2 (P25787)

Proteasome subunit alpha type-2 (UniProt P25787), EC 3.4.25.1: 74 experimental structures on GenesisL1, 1 ligand bound, 74 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P25787
Protein
Proteasome subunit alpha type-2
EC
3.4.25.1
Experimental structures
74
Predicted models
0
Ligands
1
Pockets
74 · 20 records with a druggable one

Structures

74 records of P25787 in the MolNFT archive: 74 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
4R3OHuman Constitutive 20S Proteasomex-ray diffractionB, P——
4R3OHuman constitutive 20S proteasomex-ray diffractionB, P——
4R67Human constitutive 20S proteasome in complex with carfilzomibx-ray diffractionB, P, d, r——
4R67Human constitutive 20S proteasome in complex with carfilzomibx-ray diffractionB, P, d, r——
5A0QCryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome coreelectron microscopyB, P——
5GJQStructure of the human 26S proteasome bound to USP14-ubalelectron microscopyC, i——
5GJRAn atomic structure of the human 26S proteasomeelectron microscopyC, i——
5L4GThe human 26S proteasome at 3.9 Aelectron microscopyO, B——
5LE5Native human 20S proteasome at 1.8 Angstromx-ray diffractionA, OCL—
5LE5Native human 20S proteasome at 1.8 ångströmx-ray diffractionA, OCL—
5LEXNative human 20S proteasome in Mg-Acetate at 2.2 Angstromx-ray diffractionA, O——
5LEXNative human 20S proteasome in mg-acetate at 2.2 ångströmx-ray diffractionA, O——
5LEYHuman 20S proteasome complex with oprozomib at 1.9 ångströmx-ray diffractionA, OCL—
5LEZHuman 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstromx-ray diffractionA, O——
5LEZHuman 20S proteasome complex with oprozomib in mg-acetate at 2.2 ångströmx-ray diffractionA, O——
5LF0Human 20S proteasome complex with Epoxomicin at 2.4 Angstromx-ray diffractionA, OCL4 (best 0.79)
5LF0Human 20S proteasome complex with epoxomicin at 2.4 ångströmx-ray diffractionA, OCL—
5LF1Human 20S proteasome complex with dihydroeponemycin at 2.0 ångströmx-ray diffractionA, OCL—
5LF3Human 20S proteasome complex with Bortezomib at 2.1 Angstromx-ray diffractionA, OCL6 (best 0.80)
5LF3Human 20S proteasome complex with bortezomib at 2.1 ångströmx-ray diffractionA, OCL—
5LF4Human 20S proteasome complex with Delanzomib at 2.0 Angstromx-ray diffractionA, OCL—
5LF4Human 20S proteasome complex with delanzomib at 2.0 ångströmx-ray diffractionA, OCL—
5LF6Human 20S proteasome complex with Z-lly-ketoaldehyde at 2.1 ångströmx-ray diffractionA, OCL—
5LF7Human 20S proteasome complex with Ixazomib at 2.0 Angstromx-ray diffractionA, OCL—
5LF7Human 20S proteasome complex with ixazomib at 2.0 ångströmx-ray diffractionA, OCL—
5LN3The human 26S proteasome at 6.8 ang.electron microscopyB——
5M32Human 26S proteasome in complex with Oprozomibelectron microscopyA, O—6 (best 0.80)
5M32Human 26S proteasome in complex with oprozomibelectron microscopyA, O——
5T0GStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyH—1 (best 0.84)
5T0GStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyH——
5T0HStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyH——
5T0IStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyH——
5T0JStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyH——
5VFONucleotide-driven triple-state remodeling of the aaa-ATPase channel in the activated human 26S…electron microscopyH, h——
5VFRNucleotide-driven triple-state remodeling of the aaa-ATPase channel in the activated human 26S…electron microscopyH, h——
5VFTNucleotide-driven triple-state remodeling of the aaa-ATPase channel in the activated human 26S…electron microscopyH, h——
5VFUNucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S…electron microscopyH, h——
6AVOCryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively…electron microscopyP, b——
6E5BHuman Immunoproteasome 20S particle in complex with compound 1x-ray diffractionA, O——
6E5BHuman immunoproteasome 20S particle in complex with compound 1x-ray diffractionA, O——
6KWYHuman PA200-20S complexelectron microscopyA, O——
6MSDCryo-EM structures and dynamics of substrate-engaged human 26S proteasomeelectron microscopyH, h—3 (best 0.83)
6MSKCryo-EM structures and dynamics of substrate-engaged human 26S proteasomeelectron microscopyH, h—3 (best 0.79)
6R70Endogeneous native human 20S proteasomeelectron microscopyA, O——
6REYHuman 20S-PA200 proteasome complexelectron microscopyB, P——
6RGQHuman 20S proteasomeelectron microscopyB, P——
6WJNSd-like state of human 26S proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin…electron microscopyH, h——
6XMJHuman 20S proteasome bound to an engineered 11S (PA26) activatorelectron microscopyB——
7AWEHuman immunoproteasome 20S particle in complex with [(1R)-2-(1…x-ray diffractionB, P——
7B12HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH…x-ray diffractionB, P——
7B12Human immunoproteasome 20S particle in complex with [2-(3…x-ray diffractionB, P——
7LXVStructure of human 20S proteasome with bound mpi-5electron microscopyA, O——
7NHTAkirin2 bound human proteasomeelectron microscopyA——
7NHTAKIRIN2 bound human proteasomeelectron microscopyA——
7PG9Human 20S proteasomeelectron microscopyB, P——
7QXXProteasome-ZFAND5 Complex Z+E stateelectron microscopyH, h—3 (best 0.83)
7QY7Proteasome-ZFAND5 Complex Z-A stateelectron microscopyH, h—2 (best 0.81)
7V5G20S+monoUb-CyclinB1-NT (S1)electron microscopyW, P—5 (best 0.79)
7V5G20S+MONOUB-CYCLINB1-nt (S1)electron microscopyW, P——
7V5M20S+monoUb-CyclinB1-NT (S2)electron microscopyB, P——

14 records more on the page itself.

Ligands

  • CL · Chloride ion · in 13 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.